Cancer-killing viruses provide inspiration for COVID-19 vaccine


BioCanRx Scientific Director Dr. John Bell and network investigator Dr. Carolina Ilkow are using their work in cancer immunotherapy at the Ottawa Hospital Research Institute to help pioneer a vaccine for COVID-19.


Ilkow, Bell and their research teams are using every tool in their immunotherapy arsenal to try to provoke an immune response to COVID-19. Rather than trying to engineer an immune-stimulating reaction for the typical target of cancer, they are honing in on a way to get the body to respond to COVID instead. They are doing this by engineering the original cancer-fighting viruses “so that they produce small pieces of the COVID-19 virus”.


You can read more about how this research is supporting the global pandemic effort here:


Below are a few news articles that explore this research further:
Ottawa Citizen:
Ottawa Matters – 1310 News:
CTV Ottawa:
Science Rendezvous: